logo

$5 And Under

Share SHARE

Roundy's Inc. (RNDY) reported fourth quarter adjusted net income from continuing operations of $0.07 per share after the bell Wednesday, compared to $0.13 per share last year. The consensus estimate was for EPS of $0.03. The stock is now up 0.57 on 27K shares. Roundy's was range-bound throughout Wednesday's...

Infosonics Corp. (IFON) reported fourth quarter EPS of $0.05 Wednesday morning, up from $0.01 in the prior year period. Infosonics gapped open sharply higher Wednesday and is now up 1.12 at $2.82 on above average volume. The stock has surged to its highest level since mid-September.

e-Future Information Technology (EFUT) reported fourth quarter adjusted EPS of $0.94 after the bell Tuesday, with revenues of $20.9 million. e-Future Information Technology has gapped open sharply higher Wednesday morning and is now up 1.11 at $5.24 on above average volume. The stock has jumped to over a 5-month high.

Novogen Ltd. (NVGN) confirmed Wednesday morning that TRXE-009 is showing the potential to become an important new therapy for adult and pediatric brain cancer. Novogen gapped open sharply higher Wednesday morning and is now up 1.69 at $4.20 on strong volume. The stock has surged to a 2 1/2 month high.

Career Education Corp. (CECO) reported fourth quarter operating income of $2.4 million after the close Tuesday, compared to an operating loss of $2.3 million in the prior year. Total revenue was $174.2 million, a 12.6 percent decrease from $199.4 million last year. The stock is now up 0.67 on 10K shares. Career...

Orexigen Therapeutics Inc. (OREX) has been climbing steadily since the open of trade Tuesday and is currently higher by 1.39 at $7.18 on the highest volume in over 2 months. Orexigen Therapeutics has surged past resistance and has set over an 11-month high.

McDermott International Inc. (MDR) reported fourth quarter EPS of $0.03 after the bell Monday, compared to the loss of $1.38 last year. Analysts expected a loss of $0.06 per share. For the full year 2015, the company projects revenues of $3.3 billion to $3.6 billion, while analysts expect $2.79 billion....

Emulex Corp. (ELX) announced after the bell Wednesday that it agreed to be acquired by Avago Technologies (AVGO) in an all-cash deal valued at about $606 million. Emulex gapped open sharply higher Thursday morning and is now up 1.62 at $7.98 on the highest volume in 10 months. The stock has jumped...

Helios & Matheson Analytics (HMNY) has been gaining ground since the open of trade Tuesday and is currently higher by 0.93 at $3.40, with volume at a 9-month high. Helios & Matheson Analytics has surged to a 5-month high and has re-crossed its 200-day moving average.

Angie's List Inc. (ANGI) reported fourth quarter EPS of $0.26 Wednesday morning, up from $0.05 in the previous year. The consensus estimate was for EPS of $0.22. Angie's List gapped open sharply higher Wednesday and climbed in early trade, before settling into a range. Shares finished with a gain...

Angie's List Inc. (ANGI) reported fourth quarter EPS of $0.26 Wednesday morning, up from $0.05 in the previous year. The consensus estimate was for EPS of $0.22. Angie's List gapped open sharply higher Wednesday morning and is now up 2.29 at $7.18 on above average volume. The stock has surged to a 3 1/2 month high.

J. C. Penney Co. (JCP) has broken out higher in the last few minutes of trade on increased volume. The stock is now up 0.18 at $8.31. J. C. Penney is challenging the upper end of over a 5-week trading range, as well as its 200-day moving average.

Capnia Inc. (CAPN) announced the first U.S. commercial sales of its CoSense End-Tidal Carbon Monoxide Monitors and single-use sampling sets Tuesday morning. Capnia has risen sharply in early trade Wednesday and is now up 2.47 at $4.90. The stock is adding to yesterday's gains and has surged to a 3-month...

Rosetta Genomics Ltd. (ROSG) announced Tuesday morning that it received a U.S. patents for the use of miR-34a for the treatment of p53-associated cancers. The company also received a European patent for the specific composition for miR-451. Rosetta Genomics gapped up slightly Tuesday and spiked higher...

Celsus Therapeutics (CLTX) announced Tuesday morning that its Phase II study of MRX-6 cream 2% in a pediatric population with mild to moderate atopic dermatitis did not meet its primary endpoint. Celsus Therapeutics gapped open dramatically lower Tuesday, but moved in a narrow range throughout the...

Follow RTT